CircFOXP1 alleviates brain injury after acute ischemic stroke by regulating STAT3/apoptotic signaling

Jialei Yang1, Wanting He1, Lian Gu2

  • 1School of Public Health, Guangxi Medical University, Nanning, Guangxi, China; Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning, Guangxi, China.

Insights

Circular RNA FOXP1 (circFOXP1) is decreased in acute ischemic stroke (AIS) patients. Restoring circFOXP1 levels may protect against brain injury by regulating STAT3 signaling and apoptosis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) play roles in acute ischemic stroke (AIS) pathology.
  • The specific role of circFOXP1 in AIS remains uninvestigated.

Purpose of the Study:

  • To investigate the expression and function of circFOXP1 in AIS.
  • To elucidate the underlying molecular mechanisms of circFOXP1 in cerebral ischemia.

Main Methods:

  • circFOXP1 expression analysis in AIS patients' blood.
  • In vitro studies using oxygen-glucose deprivation/reperfusion (OGD/R) models.
  • In vivo studies with adeno-associated virus (AAV)-mediated circFOXP1 overexpression in a transient middle cerebral artery occlusion (tMCAO) model.
  • Mechanistic studies involving QKI, STAT3 ubiquitination, and apoptosis signaling.

Main Results:

  • circFOXP1 expression was significantly reduced in AIS patients and correlated with disease severity and prognosis.
  • circFOXP1 knockdown exacerbated OGD/R-induced apoptosis, while overexpression inhibited it.
  • AAV-mediated circFOXP1 delivery improved neurological function and recovery in a mouse model of ischemic stroke.
  • Hypoxia reduced circFOXP1 biogenesis via decreased QKI expression.
  • circFOXP1 inhibited STAT3 degradation by reducing its ubiquitination, thereby alleviating ischemic brain injury.

Conclusions:

  • circFOXP1 is downregulated in AIS and plays a protective role against cerebral ischemia.
  • circFOXP1 alleviates brain injury by inhibiting STAT3 protein degradation and subsequent apoptotic signaling.
  • circFOXP1 represents a potential therapeutic target for AIS.